RHPN2
Rhophilin-2
Also known as: RHPN2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IUC4
- Gene
- RHPN2
- Ensembl
- ENSG00000131941
- Chromosome
- 19
- Canonical length
- 686 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes a member of the rhophilin family of Ras-homologous (Rho)-GTPase binding proteins. The encoded protein binds both GTP- and GDP-bound RhoA and GTP-bound RhoB and may be involved in the organization of the actin cytoskeleton. [provided by RefSeq, Apr 2009]
Canonical amino-acid sequenceUniProt
686 residues, UniProt reviewed canonical sequence.
>Q8IUC4|RHPN2
1 MTDALLPAAP QPLEKENDGY FRKGCNPLAQ TGRSKLQNQR AALNQQILKA VRMRTGAENL
61 LKVATNSKVR EQVRLELSFV NSDLQMLKEE LEGLNISVGV YQNTEEAFTI PLIPLGLKET
121 KDVDFAVVLK DFILEHYSED GYLYEDEIAD LMDLRQACRT PSRDEAGVEL LMTYFIQLGF
181 VESRFFPPTR QMGLLFTWYD SLTGVPVSQQ NLLLEKASVL FNTGALYTQI GTRCDRQTQA
241 GLESAIDAFQ RAAGVLNYLK DTFTHTPSYD MSPAMLSVLV KMMLAQAQES VFEKISLPGI
301 RNEFFMLVKV AQEAAKVGEV YQQLHAAMSQ APVKENIPYS WASLACVKAH HYAALAHYFT
361 AILLIDHQVK PGTDLDHQEK CLSQLYDHMP EGLTPLATLK NDQQRRQLGK SHLRRAMAHH
421 EESVREASLC KKLRSIEVLQ KVLCAAQERS RLTYAQHQEE DDLLNLIDAP SVVAKTEQEV
481 DIILPQFSKL TVTDFFQKLG PLSVFSANKR WTPPRSIRFT AEEGDLGFTL RGNAPVQVHF
541 LDPYCSASVA GAREGDYIVS IQLVDCKWLT LSEVMKLLKS FGEDEIEMKV VSLLDSTSSM
601 HNKSATYSVG MQKTYSMICL AIDDDDKTDK TKKISKKLSF LSWGTNKNRQ KSASTLCLPS
661 VGAARPQVKK KLPSPFSLLN SDSSWYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RHPN2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 33 nTPM
Expression across tissuesHPA
Tissue
- stomach: 33 nTPM
- prostate: 26 nTPM
- colon: 22 nTPM
- duodenum: 20 nTPM
- retina: 19 nTPM
- liver: 18 nTPM
Single-cell type
- foveolar cells: 503 nCPM
- endometrial glandular cells: 445 nCPM
- colonocytes: 437 nCPM
- endometrial luminal cells: 391 nCPM
- prostatic glandular cells: 355 nCPM
- endometrial ciliated cells: 351 nCPM
Immune cell
- naive B-cell: 0.3 nTPM
- memory B-cell: 0.2 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- choroid plexus: 11 nTPM
- thalamus: 9.6 nTPM
- midbrain: 8.8 nTPM
- medulla oblongata: 7.7 nTPM
- white matter: 7.4 nTPM
- pons: 7.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.76
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.32
- DepMap mean gene effect
- 0
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
- PDZ domain
- BRO1 domain
- HR1 rho-binding domain
- PDZ superfamily
- HR1 repeat superfamily
- BRO1 domain superfamily
- Rhophilin-1/2
- Hr1 repeat
- BRO1-like domain
- Rhophilin-2, BRO1 domain
- Rhophilin-2, HR1 domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RHPN2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RHPN2 as an antibody target. Whether an autoantibody or antibody against RHPN2 could matter depends on whether native RHPN2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RHPN2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RHPN2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...